Gema Díaz Gil

Profesor Titular

Universidad Rey Juan Carlos

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gema Díaz Gil is a Profesor Titular at Universidad Rey Juan Carlos in Spain. Her research primarily focuses on the genetic and epigenetic factors associated with post-COVID-19 conditions, as evidenced by her recent publications examining the relationship between various polymorphisms and long-COVID symptoms. She has contributed significantly to the understanding of how DNA methylation levels may relate to health outcomes in COVID-19 survivors.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (4)

Rocco Giordano

Aalborg University

DENMARK

View details

Francisco Gómez-Esquer

Universidad Rey Juan Carlos

SPAIN

View details

Pablo Ryan

Instituto de Investigación Sanitaria Gregorio Marañón

SPAIN

View details

Julio Ramiro Bargueño

Profesor Titular de Universidad

Universidad Rey Juan Carlos - Campus de Fuenlabrada

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gema Díaz Gil

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

ACE1 rs1799752 Polymorphism Is not Associated With the Presence of Post‐COVID‐19 Condition

Are ACE2 rs2285666 and TMPRSS2 rs12329760 polymorphisms a risk factor for the development of Post-COVID-19 condition?

DNA Salivary Methylation Levels of the ACE2 Promoter Are Not Related to ACE2 (rs2285666 and rs2074192), TMPRSS2 (rs12329760 and rs2070788) and ACE1 rs1799752 Polymorphisms in COVID-19 Survivors with Post-COVID-19 Condition

DNA methylation levels of the ACE2 promoter are not associated with symptoms-severity and related-disability in previously hospitalized COVID-19 survivors

Post-COVID-19 Pain Is Not Associated with DNA Methylation Levels of the <i>ACE2</i> Promoter in COVID-19 Survivors Hospitalized Due to SARS-CoV-2 Infection

DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19

Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

An Experimental Murine Model to Study Lipoatrophia Semicircularis

Apolipoprotein E (ApoE) ε4 Genotype (ApoE rs429358—ApoE rs7412 Polymorphisms) Is Not Associated with Long COVID Symptoms in Previously Hospitalized COVID-19 Survivors

ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors

Genetic Association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) Polymorphisms with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

Post-COVID Pain Is Not Associated with Inflammatory Polymorphisms in People Who Had Been Hospitalized by COVID-19

Are Pain Polymorphisms Associated with the Risk and Phenotype of Post-COVID Pain in Previously Hospitalized COVID-19 Survivors?

A Variant of the Deltoid Muscle and Its Clinical Implications: A Cadaveric Study

Fear of pain moderates the relationship between self-reported fatigue and methionine allele of catechol-O-methyltransferase gene in patients with fibromyalgia.

Effects of COMT Genotypes on Working Memory Performance in Fibromyalgia Patients

Collaborators (4)

Rocco Giordano

Francisco Gómez-Esquer

Pablo Ryan

Julio Ramiro Bargueño

Make your next move.